Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Surgical Apparatus

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1501248

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1501248

Neurosurgical Product Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 86 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global neurosurgical products market has been rising at a healthy pace in recent years, and this trend is anticipated to continue in the foreseeable future. The significant growth in developed countries is attributed to advancements in medical science and an ultra-modern healthcare infrastructure. Efforts from medical device manufacturers for technological advances and product innovation have also played a crucial role in the market's growth.

Growing Geriatric Population Boosting Market Demand

The increasing geriatric population globally is a key factor behind the growth of the neurosurgical products market. Developing countries such as China and India are anticipated to account for a larger geriatric population base compared to developed nations such as the U.S. The elderly are more prone to hemorrhage and stroke as compared to their younger counterparts. The American Heart Association notes that the risk of stroke is twice as high among individuals above the age of 55 years. These factors are expected to drive the global neurosurgical products market significantly.

Governmental Funding and Awareness Programs for Neurological Conditions Fuels Growth

Increasing funding from governments and public healthcare agencies for the development of neurosurgical products aims to reduce the burden of neurological disorders on healthcare systems. Availability of adequate funds will help researchers develop new treatments for neurological conditions. For instance, the National Institute of Neurological Disorders and Stroke in the U.S. increased grants substantially, reflecting a commitment to advancing neurosurgical research.

Rising Incidence of Brain Tumors Driving Demand for Neurosurgical Products

The rising incidence of brain tumors is significantly stoking the demand for neurosurgical products. Neurosurgical products such as endoscopes and stereotactic radiosurgery systems find extensive application in detecting and removing brain tumors. Statistics from GLOBOCAN indicate a substantial increase in the number of brain tumor cases globally. Similarly, the American Brain Tumor Association reports a considerable number of new cases of brain tumors, with a notable percentage being malignant. This trend underscores the need for advanced neurosurgical products.

Awareness Campaigns Enhancing Market Growth

Rising awareness about neurological disorders is also benefiting the neurosurgical products market. In several parts of the world, both governmental and non-governmental organizations are carrying out awareness programs for the early detection of neurological conditions. For instance, Brain Awareness Week is organized annually in New Zealand, featuring updates and developments from neuroscientists and clinicians in neurology. In the U.S., the National Institute of Neurological Disorders and Stroke organizes the Know Stroke campaign each year to spread awareness about stroke symptoms and available treatments.

Preference for Non-surgical Therapies Posing Challenges

Despite the promising growth, the market faces challenges due to the availability of alternative treatments for neurological diseases. Drug therapies are often the first line of treatment for neurological conditions, with neurosurgery being considered only if non-surgical therapies prove ineffective. Additionally, stringent regulations and long approval processes for medical devices, especially stereotactic neurosurgical products, can delay their commercial availability, posing a challenge to market growth.

Competitive Analysis

  • Integra LifeSciences Holdings Corporation
  • KARL STORZ GmbH & Co. KG
  • Medtronic plc
  • Johnson & Johnson Services, Inc.
  • Stryker Corporation
  • Elekta AB
  • Terumo Corporation
  • Penumbra, Inc.
  • B. Braun Melsungen AG
  • Varian Medical Systems, Inc.
  • Other

Key Market Segmentation

By Condition

  • Hydrocephalus
  • Aneurysms
  • Arteriovenous malformations
  • Pituitary and intracranial tumors

By Procedure

  • Open Neurosurgery
  • Neurovascular and Minimally Invasive Surgery

By Product Type

  • Shunts
  • Neurosurgical Endoscope
  • Stereotactic Radio-surgery System
  • Embolization Products
  • Aneurysm and AVM Clips

By Geography

  • North America
  • Europe
  • Asia-Pacific
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Neurosurgical Product Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. PESTLE Analysis

3. Global Neurosurgical Product Market Outlook, 2018 - 2031

  • 3.1. Global Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Hydrocephalus
      • 3.1.1.2. Aneurysms
      • 3.1.1.3. Arteriovenous malformations
      • 3.1.1.4. Pituitary and intracranial tumors
  • 3.2. Global Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Open Neurosurgery
      • 3.2.1.2. Neurovascular and Minimally Invasive Surgery
  • 3.3. Global Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Shunts
      • 3.3.1.2. Neurosurgical Endoscope
      • 3.3.1.3. Stereotactic Radio-surgery System
      • 3.3.1.4. Embolization Products
      • 3.3.1.5. Aneurysm and AVM Clips
  • 3.4. Global Neurosurgical Product Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Neurosurgical Product Market Outlook, 2018 - 2031

  • 4.1. North America Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Hydrocephalus
      • 4.1.1.2. Aneurysms
      • 4.1.1.3. Arteriovenous malformations
      • 4.1.1.4. Pituitary and intracranial tumors
  • 4.2. North America Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Open Neurosurgery
      • 4.2.1.2. Neurovascular and Minimally Invasive Surgery
  • 4.3. North America Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Shunts
      • 4.3.1.2. Neurosurgical Endoscope
      • 4.3.1.3. Stereotactic Radio-surgery System
      • 4.3.1.4. Embolization Products
      • 4.3.1.5. Aneurysm and AVM Clips
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Neurosurgical Product Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 4.4.1.2. U.S. Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 4.4.1.3. U.S. Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.4. Canada Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 4.4.1.5. Canada Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 4.4.1.6. Canada Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Neurosurgical Product Market Outlook, 2018 - 2031

  • 5.1. Europe Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Hydrocephalus
      • 5.1.1.2. Aneurysms
      • 5.1.1.3. Arteriovenous malformations
      • 5.1.1.4. Pituitary and intracranial tumors
  • 5.2. Europe Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Open Neurosurgery
      • 5.2.1.2. Neurovascular and Minimally Invasive Surgery
  • 5.3. Europe Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Shunts
      • 5.3.1.2. Neurosurgical Endoscope
      • 5.3.1.3. Stereotactic Radio-surgery System
      • 5.3.1.4. Embolization Products
      • 5.3.1.5. Aneurysm and AVM Clips
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Neurosurgical Product Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. Germany Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. Germany Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. U.K. Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. U.K. Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. U.K. Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.7. France Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 5.4.1.8. France Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 5.4.1.9. France Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.10. Italy Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 5.4.1.11. Italy Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 5.4.1.12. Italy Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.13. Turkey Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 5.4.1.14. Turkey Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 5.4.1.15. Turkey Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.16. Russia Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 5.4.1.17. Russia Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 5.4.1.18. Russia Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Neurosurgical Product Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Hydrocephalus
      • 6.1.1.2. Aneurysms
      • 6.1.1.3. Arteriovenous malformations
      • 6.1.1.4. Pituitary and intracranial tumors
  • 6.2. Asia Pacific Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Open Neurosurgery
      • 6.2.1.2. Neurovascular and Minimally Invasive Surgery
  • 6.3. Asia Pacific Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Shunts
      • 6.3.1.2. Neurosurgical Endoscope
      • 6.3.1.3. Stereotactic Radio-surgery System
      • 6.3.1.4. Embolization Products
      • 6.3.1.5. Aneurysm and AVM Clips
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Neurosurgical Product Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. China Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. China Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. Japan Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. Japan Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. Japan Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. South Korea Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. South Korea Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. South Korea Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. India Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. India Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. India Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Neurosurgical Product Market Outlook, 2018 - 2031

  • 7.1. Latin America Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Hydrocephalus
      • 7.1.1.2. Aneurysms
      • 7.1.1.3. Arteriovenous malformations
      • 7.1.1.4. Pituitary and intracranial tumors
  • 7.2. Latin America Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Open Neurosurgery
      • 7.2.1.2. Neurovascular and Minimally Invasive Surgery
  • 7.3. Latin America Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Shunts
      • 7.3.1.2. Neurosurgical Endoscope
      • 7.3.1.3. Stereotactic Radio-surgery System
      • 7.3.1.4. Embolization Products
      • 7.3.1.5. Aneurysm and AVM Clips
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Neurosurgical Product Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. Brazil Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. Brazil Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Mexico Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Mexico Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Mexico Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. Argentina Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. Argentina Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. Argentina Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Neurosurgical Product Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Hydrocephalus
      • 8.1.1.2. Aneurysms
      • 8.1.1.3. Arteriovenous malformations
      • 8.1.1.4. Pituitary and intracranial tumors
  • 8.2. Middle East & Africa Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Open Neurosurgery
      • 8.2.1.2. Neurovascular and Minimally Invasive Surgery
  • 8.3. Middle East & Africa Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Shunts
      • 8.3.1.2. Neurosurgical Endoscope
      • 8.3.1.3. Stereotactic Radio-surgery System
      • 8.3.1.4. Embolization Products
      • 8.3.1.5. Aneurysm and AVM Clips
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Neurosurgical Product Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 8.4.1.2. GCC Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 8.4.1.3. GCC Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.4. South Africa Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 8.4.1.5. South Africa Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 8.4.1.6. South Africa Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.7. Egypt Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 8.4.1.8. Egypt Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 8.4.1.9. Egypt Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.10. Nigeria Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 8.4.1.11. Nigeria Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 8.4.1.12. Nigeria Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product vs Indication Heatmap
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Integra LifeSciences Holdings Corporation
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. KARL STORZ GmbH & Co. KG.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Medtronic plc
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Johnson & Johnson Services, Inc.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Stryker Corporation
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Elekta AB
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Terumo Corporation
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Penumbra, Inc.
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Others
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!